ARCUTIS BIOTHERAPEUTICS Receives Buy Recommendation and Projected 82.88% Upside from Jefferies Analysts
🌥️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT) is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for various skin [...]
Travere Therapeutics Set to Announce Quarterly Earnings Tomorrow, Register for Conference Call Now!
🌥️Trending News Travere Therapeutics ($NASDAQ:TVTX), formerly known as Retrophin Inc., is a biopharmaceutical company focused on developing and commercializing treatments [...]
Deadline Approaching for Sage Therapeutics Investors to File Class Action Lawsuit, Law Firm Reminds
🌧️Trending News Sage Therapeutics ($NASDAQ:SAGE) is a biopharmaceutical company that focuses on developing and commercializing novel medicines to treat neurological [...]
Arcus Biosciences Intrinsic Value – Barclays Raises Price Target and Gives Arcus Biosciences “Overweight” Rating in Positive Research Report
☀️Trending News Arcus Biosciences ($NYSE:RCUS) is a clinical-stage biopharmaceutical company that focuses on developing innovative cancer treatments. The company's stock [...]
Merus N.v Intrinsic Value Calculation – UBS Group initiates coverage on Merus N.V with a “buy” rating and $72 price target
🌥️Trending News Merus ($NASDAQ:MRUS) N.V is a biotechnology company based in the Netherlands that focuses on the development of innovative [...]
Allogene Therapeutics Soars with Strong Market Close at 2.65, Up 1.15
☀️Trending News Allogene Therapeutics ($NASDAQ:ALLO) Inc. is a biotechnology company that specializes in developing innovative allogeneic CAR T cell therapies [...]
State Street Corp Makes Major Move with Zentalis Pharmaceuticals Holdings in Strategic Transaction
🌥️Trending News State Street Corp, a leading financial services company, recently announced a significant transaction with Zentalis Pharmaceuticals ($NASDAQ:ZNTL) Holdings. [...]
Vertex Pharmaceuticals sees significant decrease in position by Bleakley Financial Group LLC during Q3.
☀️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) Incorporated is a biotechnology company that focuses on developing and commercializing therapies for the treatment [...]
Bank of America Sets New $15.00 Price Target for Amicus Therapeutics Following Positive Readout
☀️Trending News Amicus Therapeutics ($NASDAQ:FOLD) is a global biotechnology company dedicated to developing and delivering innovative therapies for rare and [...]
Cytokinetics Stock Intrinsic Value – Cytokinetics to Reveal Third Quarter 2024 Financial Results on November 6th
🌥️Trending News Cytokinetics ($NASDAQ:CYTK) is a biopharmaceutical company that specializes in developing treatments for serious and life-threatening diseases. They are [...]
